The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...
MarinHealth Medical Center Surgeons Perform New AI-Powered Aquablation Procedure for the Treatment of Benign Prostatic ...
Manipal Hospitals Sarjapur Road hosted a session on HoLEP for Benign Prostatic Hyperplasia. This innovative technique, led by ...
"Acibadem Sistina" Clinical Hospital is the only hospital in the country that offers the minimally invasive Rezūm™ Water Vapor Therapy procedure for the treatment of benign prostatic hyperplasia. This ...
The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH). MarinHealth is ...
A full market release of the HYDROS System is expected within the current quarter.
Britain's King Charles has been recently diagnosed with cancer while undergoing treatment for an enlarged prostate or benign prostatic hyperplasia. While the type and stage of malignancy still ...
Benign prostatic hyperplasia is a prevalent condition leading to male lower urinary tract symptoms ... and patient hesitancy toward invasive treatments. First-line interventional therapy (FIT) emerges ...
Anticipated growth for ‘Saudi Arabia Benign Prostatic Hyperplasia Treatment Market’ is significant from 2024 to 2032. The market showed steady growth in 2024 and is expected to continue rising due to ...
Winter leads to an increased risk of problems related to the prostate gland in seniors. Cold weather causes urinary and ...